Skip to content

    Hind. Unilever

    HINDUNILVR
    Fast Moving Consumer Goods·24 Apr 2025
    Management Summary

    Hindustan Unilever Limited reported a subdued financial year 2025 with underlying sales and volume growth of 2%, reflecting challenging FMCG market conditions. Gross margin moderated to 50.3% and EBITDA margin to 23.5%, both down year-on-year, due to business mix and increased investments. Despite this, PAT grew 5% including the Pureit divestment. The company is strategically investing in portfolio transformation, particularly in Future Core and Market Makers segments, and strengthening distribution channels, with a near-term EBITDA margin guidance of 22-23% for the next 2-3 quarters.

    Highlights

    16
    • FY25 Turnover: ₹60,680 crores

    • FY25 Underlying Sales Growth (USG): 2%

    • FY25 Underlying Volume Growth (UVG): 2%

    • FY25 Gross Margin: 50.3% (down 50 bps YoY)

    • FY25 EBITDA Margin: 23.5% (down 30 bps YoY)

    • FY25 Profit After Tax (PAT): Grew 5% YoY (including Pureit divestment profit)

    • FY25 Total Dividend: ₹53 per share (up 26% YoY)

    • Q4 FY25 Underlying Sales Growth (USG): 3%

    • Q4 FY25 EBITDA Margin: 23.1% (down 30 bps YoY)

    • FY25 Surf Excel Turnover: Crossed ₹10,000 crores

    • FY25 Minimalist Turnover: Exceeded ₹500 crores

    • FY25 OZiva Annual Revenue Run Rate: Scaled from ₹100 crores to ₹400 crores

    • FY25 Direct Value-Weighted Distribution: 69% (400 bps step-up over 18 months)

    • FY25 Net Savings: 3.5% of turnover

    • FY25 Cash Conversion Ratio: Near 100%

    • FY25 Portfolio Shift: 200 basis points from Core to Future Core and Market Makers

    Guidance & targets

    18
    CategoryTargetPriority
    Demerger
    Ice Cream Business Demerger Completion
    by the end of financial year 2026
    High
    Growth Outlook
    H1 FY26 Performance vs H2 FY25
    better than
    Medium
    Growth Outlook
    Market Demand
    gradually improving
    Medium
    Growth Outlook
    Overall Growth Trajectory
    June quarter - September quarter should be better than what the last couple of quarters have been.
    High
    Pricing
    Price Growth
    low-single digit range
    Medium
    Pricing
    Skin Cleansing Pricing Actions
    appropriately do pricing actions
    High
    Profitability
    Gross Margin
    moderate further
    Medium
    Profitability
    EBITDA Margin
    22% to 23%
    High
    Profitability
    Foods (Tea & Coffee) Price vs Cost Hurt
    some element of price versus cost hurt
    Medium
    Profitability
    Operating Leverage Investment
    invest back the operating leverage
    High
    Profitability
    Margins Improvement
    start seeing margins to improve
    Medium
    Investment Strategy
    Focus
    growth first and EBITDA secondarily
    High
    Segment Performance
    Home Care Underlying Price Growth (UPG)
    negative UPG
    High
    Segment Performance
    Lifebuoy Sequential Improvement
    see sequential improvement
    Medium
    Market Share
    Skin Care (Glow & Lovely) Share Gain
    start gaining share
    Medium
    Market Share
    Market Share Growth (Volume-led)
    keep Increasing market share, mainly led by volume
    High
    New Segment Entry
    Prestige Beauty Segment Entry
    enter
    Medium
    Cash Flow
    Cash Conversion Ratio
    not be materially away from 100%
    High
    3 min read

    Detailed Narrative

    Hindustan Unilever Limited concluded its financial year 2025 with a subdued performance, reporting a turnover of ₹60,680 crores, alongside an underlying sales growth (USG) and underlying volume growth (UVG) of 2% each. The gross margin for the year stood at 50.3%, a 50 basis points decline year-on-year, primarily attributed to business mix and increased investments across distribution channels. EBITDA margin also saw a slight contraction of 30 basis points, settling at 23.5%. Despite these pressures, Profit After Tax (PAT) grew by 5% year-on-year, benefiting from the profit realized from the divestment of Pureit. The company also declared a total dividend of ₹53 per share for FY25, marking a 26% increase year-on-year.

    For the March quarter (Q4 FY25), the company delivered a competitive performance with a 3% USG and 2% UVG. Gross margin for the quarter was 49.8%, down 160 bps year-on-year, impacted by commodity inflation in palm oil, tea, and coffee that was not fully priced for. EBITDA margin for Q4 FY25 was 23.1%, a 30 bps decline. Segment-wise, Home Care delivered a robust 3% USG with mid-single-digit volume growth, driven by strong double-digit growth in its liquids portfolio. Beauty & Wellbeing also grew 3% in USG, with Hair Care showing high single-digit UVG. Personal Care, however, saw a decline of 3% in USG, while Foods turnover decreased by 1% due to volume decline. The Market Makers portfolio continued its strong double-digit volume growth, and the e-commerce channel achieved circa 40% gross sales value growth.

    Management outlined a strategic shift towards aggressive investment to drive future growth, particularly in "Future Core" and "Market Makers" portfolios. This includes revitalizing core brands like Lifebuoy and Glow & Lovely, expanding into new segments (e.g., Prestige beauty in FY26), and leveraging digital channels. The company reported significant progress in its direct value-weighted distribution, increasing it by 400 basis points over 18 months to 69%. Acquisitions like OZiva have scaled significantly, with its annual revenue run rate growing from ₹100 crores to ₹400 crores, and achieving profitability from an initial 40-50% EBITDA loss. Minimalist also exceeded ₹500 crores in turnover for FY25.

    Looking ahead, management expressed a bullish outlook for the near to medium term, anticipating a gradual improvement in demand driven by favorable macroeconomic conditions such as a normal monsoon, lower food and crude inflation, and monetary stimulus. They expect the first half of FY26 to perform better than the second half of FY25. The company has revised its near-term EBITDA margin guidance to 22-23% for the next 2-3 quarters, down from a previous range of 23-24%. This moderation is a deliberate strategic choice to "lean in" with investments in innovations, channels of the future, and portfolio transformation, prioritizing volume-led competitive growth over short-term margin expansion. They anticipate margins to start improving in the later half of FY26.

    Key risks and concerns discussed included the impact of commodity inflation on gross margins, particularly in Tea, Coffee, and Skin Cleansing, which may lead to further pricing actions in the coming quarters. The Nutrition Drinks category continues to face headwinds and has declined, prompting strategic actions to step up consumption and premiumization. Despite these challenges, management conveyed strong confidence in their revamped portfolio, enhanced capabilities, and the overall long-term growth potential of the Indian market, reiterating their commitment to achieving double-digit EPS growth in the medium to long term.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.